A camel-derived MERS-CoV with a variant spike protein cleavage site and distinct fusion activation properties

Jean Kaoru MilletDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY14853, USA

Monty E GoldsteinDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY14853, USA;Cornell Undergraduate Biology, Cornell University, Ithaca, NY14853, USA

Rachael N LabittDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY14853, USA;Cornell DVM Program, Cornell University, Ithaca, NY14853, USA

Hung-Lun HsuSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY14853, USA;Cornell Graduate Field of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY14853, USA

Susan DanielSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY14853, USA

Gary R WhittakerDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY14853, USACorrespondence[email protected]

A camel-derived MERS-CoV with a variant spike protein cleavage site and distinct fusion activation properties

Supplementary Figure 1

Supplementary Figure 2

Related Research Data

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A camel-derived MERS-CoV with a variant spike protein cleavage site and distinct fusion activation properties

Supplementary Figure 1

Supplementary Figure 2

Related Research Data

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date